UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies

Gynecologic oncology, 2014-05, Vol.133 (2), p.274-277

2014

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center

Gynecologic oncology, 2016-03, Vol.140 (3), p.436-442

2016

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma

Gynecologic oncology, 2016-05, Vol.141 (2), p.260-263

2016

Link zum Volltext

Verfügbarkeit prüfen

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

Gynecologic oncology, 2017-04, Vol.145 (1), p.15-20

2017

Link zum Volltext

Verfügbarkeit prüfen

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas

Gynecologic oncology, 2010-10, Vol.119 (1), p.38-42

2010

Link zum Volltext

Verfügbarkeit prüfen

Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach

Gynecologic oncology, 2017-07, Vol.146 (1), p.101-108

2017

Link zum Volltext

Verfügbarkeit prüfen

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

Gynecologic oncology, 2004-09, Vol.94 (3), p.650-654

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma

Gynecologic oncology, 2014-10, Vol.135 (1), p.49-53

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Gynecologic oncology, 2018-08, Vol.150 (2), p.274-281

2018

Link zum Volltext

Verfügbarkeit prüfen

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

Gynecologic oncology, 2009-07, Vol.114 (1), p.26-31

2009

Link zum Volltext

Verfügbarkeit prüfen

Genetic predisposition to bevacizumab-induced hypertension

Gynecologic oncology, 2017-12, Vol.147 (3), p.621-625

2017

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility

Gynecologic oncology, 2019-12, Vol.155 (3), p.473-482

2019

Link zum Volltext

Verfügbarkeit prüfen

Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers

Gynecologic oncology, 2009-11, Vol.115 (2), p.204-208

2009

Link zum Volltext

Verfügbarkeit prüfen

Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?

Gynecologic oncology, 2009-05, Vol.113 (2), p.163-169

2009

Link zum Volltext

Verfügbarkeit prüfen

Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes

Gynecologic oncology, 2016-08, Vol.142 (2), p.217-224

2016

Link zum Volltext

Verfügbarkeit prüfen

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer

Gynecologic oncology, 2006-12, Vol.103 (3), p.1083-1090

2006

Link zum Volltext

Verfügbarkeit prüfen

Improving sentinel lymph node detection rates in endometrial cancer: How many cases are needed?

Gynecologic oncology, 2009-12, Vol.115 (3), p.453-455

2009

Link zum Volltext

Verfügbarkeit prüfen

Validated gene targets associated with curatively treated advanced serous ovarian carcinoma

Gynecologic oncology, 2013-03, Vol.128 (3), p.512-517

2013

Link zum Volltext

Verfügbarkeit prüfen

The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease

Gynecologic oncology, 2008-12, Vol.111 (3), p.431-437

2008

Link zum Volltext

Verfügbarkeit prüfen

Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer

Gynecologic oncology, 2012-04, Vol.125 (1), p.25-30

2012

Link zum Volltext

Verfügbarkeit prüfen

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Cell, 2020-11, Vol.183 (5), p.1436-1456.e31

2020

Link zum Volltext

Verfügbarkeit prüfen

Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: Risk factors and associations with postoperative morbidity

Gynecologic oncology, 2013-12, Vol.131 (3), p.525-530

2013

Link zum Volltext

Verfügbarkeit prüfen

Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer

Gynecologic oncology, 2014-02, Vol.132 (2), p.299-302

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaAged

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Humans
(47)
Life Sciences & Biomedicine
(47)
Female
(45)
Middle Aged
(42)
Adult
(36)
Obstetrics & Gynecology
(36)
Oncology
(34)
Aged, 80 And Over
(30)
Obstetrics And Gynecology
(28)
Hematology, Oncology And Palliative Medicine
(26)
Neoplasm Staging
(20)
Ovarian Neoplasms - Pathology
(20)
Ovarian Cancer
(15)
Ovarian Neoplasms - Surgery
(14)
Treatment Outcome
(12)
Male
(10)
Retrospective Studies
(9)
Biological And Medical Sciences
(8)

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas

Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study

Genetic predisposition to bevacizumab-induced hypertension

Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility

Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers

Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?

Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer

Improving sentinel lymph node detection rates in endometrial cancer: How many cases are needed?

Validated gene targets associated with curatively treated advanced serous ovarian carcinoma

The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease

Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: Risk factors and associations with postoperative morbidity

Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer

Aktive Filter

Suchergebnisse filtern